المؤلفون: Del Giudice F., Flammia R. S., Chung B. I., Moschini M., Pradere B., Mari A., Soria F., Albisinni S., Krajewski W., Szydelko T., Laukhtina E., D'Andrea D., Gallioli A., Mertens L. S., Maggi M., Sciarra A., Salciccia S., Ferro M., Scornajenghi C. M., Asero V., Cattarino S., Angelis M. D., Cacciamani G. E., Autorino R., Pandolfo S. D., Falagario U. G., D'Altilia N., Mancini V., Chirico M., Cinelli F., Bettocchi C., Cormio L., Carrieri G., De Berardinis E., Busetto G. M.

المساهمون: Del Giudice, F., Flammia, R. S., Chung, B. I., Moschini, M., Pradere, B., Mari, A., Soria, F., Albisinni, S., Krajewski, W., Szydelko, T., Laukhtina, E., D'Andrea, D., Gallioli, A., Mertens, L. S., Maggi, M., Sciarra, A., Salciccia, S., Ferro, M., Scornajenghi, C. M., Asero, V., Cattarino, S., Angelis, M. D., Cacciamani, G. E., Autorino, R., Pandolfo, S. D., Falagario, U. G., D'Altilia, N., Mancini, V., Chirico, M., Cinelli, F., Bettocchi, C., Cormio, L., Carrieri, G., De Berardinis, E., Busetto, G. M.

مصطلحات موضوعية: bcg strain, bcg-rivm, bcg-tice, bladder cancer, cancer-specific survival, progression-free survival, re-tur, recurrence-free survival

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35205635; info:eu-repo/semantics/altIdentifier/wos/WOS:000764214600001; volume:14; issue:4; firstpage:1; lastpage:11; numberofpages:11; journal:CANCERS; http://hdl.handle.net/11573/1618365Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85124948130

الإتاحة: https://doi.org/10.3390/cancers14040887Test
http://hdl.handle.net/11573/1618365Test

المؤلفون: Del Giudice, Francesco, Flammia, Rocco Simone, Chung, Benjamin B.I., Moschini, Marco, Pradere, Benjamin, Mari, Andrea, Soria, Francesco, Albisinni, Simone, Krajewski, Wojciech, Szydełko, Tomasz, Laukhtina, Ekaterina, D'Andrea, David, Gallioli, Andrea, Mertens, Laura L.S., Maggi, Martina, Sciarra, Alessandro, Salciccia, Stefano, Ferro, Matteo, Scornajenghi, Carlo Maria, Asero, Vincenzo, Cattarino, Susanna, Angelis, Mario De, Cacciamani, Giovanni G.E., Autorino, Riccardo, Pandolfo, Savio Domenico, Falagario, Ugo Giovanni, D’Altilia, Nicola, Mancini, Vito, Chirico, Marco, Cinelli, Francesco, Bettocchi, Carlo, Cormio, Luigi, Carrieri, Giuseppe, De Berardinis, Ettore, Busetto, Gian Maria

المصدر: Cancers (Basel), 14 (4

مصطلحات موضوعية: Cancérologie, Sciences bio-médicales et agricoles, BCG strain, BCG-RIVM, BCG-TICE, Bladder cancer, Cancer-specific survival, Progression-free survival, Re-TUR, Recurrence-free survival

وصف الملف: 1 full-text file(s): application/pdf

العلاقة: uri/info:doi/10.3390/cancers14040887; uri/info:scp/85124948130; https://dipot.ulb.ac.be/dspace/bitstream/2013/341547/1/doi_325191.pdfTest; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/341547Test

الإتاحة: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/341547Test

المؤلفون: Francesco Del Giudice, Rocco Simone Flammia, Benjamin I. Chung, Marco Moschini, Benjamin Pradere, Andrea Mari, Francesco Soria, Simone Albisinni, Wojciech Krajewski, Tomasz Szydełko, Ekaterina Laukhtina, David D’Andrea, Andrea Gallioli, Laura S. Mertens, Martina Maggi, Alessandro Sciarra, Stefano Salciccia, Matteo Ferro, Carlo Maria Scornajenghi, Vincenzo Asero, Susanna Cattarino, Mario De Angelis, Giovanni E. Cacciamani, Riccardo Autorino, Savio Domenico Pandolfo, Ugo Giovanni Falagario, Nicola D’Altilia, Vito Mancini, Marco Chirico, Francesco Cinelli, Carlo Bettocchi, Luigi Cormio, Giuseppe Carrieri, Ettore De Berardinis, Gian Maria Busetto, on behalf of European Association of Urology (EAU)—Young Academic Urologists (YAU) Urothelial Cancer Working Party

المصدر: Cancers; Volume 14; Issue 4; Pages: 887

مصطلحات موضوعية: bladder cancer, re-TUR, BCG strain, BCG-TICE, BCG-RIVM, recurrence-free survival, progression-free survival, cancer-specific survival

وصف الملف: application/pdf

العلاقة: Molecular Cancer Biology; https://dx.doi.org/10.3390/cancers14040887Test

الإتاحة: https://doi.org/10.3390/cancers14040887Test

المؤلفون: Del Giudice, Francesco, Busetto, Gian Maria, Gross, Martin S, Maggi, Martina, Sciarra, Alessandro, Salciccia, Stefano, Ferro, Matteo, Sperduti, Isabella, Flammia, Simone, Canale, Vittorio, Chung, Benjamin I, Conti, Simon L, Eisenberg, Michael L, Skinner, Eila C, De Berardinis, Ettore

المساهمون: Del Giudice, Francesco, Busetto, Gian Maria, Gross, Martin S, Maggi, Martina, Sciarra, Alessandro, Salciccia, Stefano, Ferro, Matteo, Sperduti, Isabella, Flammia, Simone, Canale, Vittorio, Chung, Benjamin I, Conti, Simon L, Eisenberg, Michael L, Skinner, Eila C, De Berardinis, Ettore

مصطلحات موضوعية: BCG strain, BCG-Connaught, BCG-RIVM, BCG-TICE, bladder cancer, cancer-specific survival, progression-free survival, Re-TUR, recurrence-free survival

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33675400; info:eu-repo/semantics/altIdentifier/wos/WOS:000625739500001; numberofpages:8; journal:JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; http://hdl.handle.net/11573/1516485Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85102267951

الإتاحة: https://doi.org/10.1007/s00432-021-03571-0Test
http://hdl.handle.net/11573/1516485Test

المؤلفون: Francesco, Del Giudice, Rocco Simone, Flammia, Benjamin I, Chung, Marco, Moschini, Benjamin, Pradere, Andrea, Mari, Francesco, Soria, Simone, Albisinni, Wojciech, Krajewski, Tomasz, Szydełko, Ekaterina, Laukhtina, David, D'Andrea, Andrea, Gallioli, Laura S, Mertens, Martina, Maggi, Alessandro, Sciarra, Stefano, Salciccia, Matteo, Ferro, Carlo Maria, Scornajenghi, Vincenzo, Asero, Susanna, Cattarino, Mario, De Angelis, Giovanni E, Cacciamani, Riccardo, Autorino, Savio Domenico, Pandolfo, Ugo Giovanni, Falagario, Nicola, D'Altilia, Vito, Mancini, Marco, Chirico, Francesco, Cinelli, Carlo, Bettocchi, Luigi, Cormio, Giuseppe, Carrieri, Ettore, De Berardinis, Gian Maria, Busetto, On Behalf Of European Association Of Urology Eau-Young Academic Urologists Yau Urothelial Cancer Working Party

المساهمون: Urology

المصدر: Cancers
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Cancers; Volume 14; Issue 4; Pages: 887
Cancers, 14(4):887. Multidisciplinary Digital Publishing Institute (MDPI)
European Association of Urology (EAU)-Young Academic Urologists (YAU) Urothelial Cancer Working Party 2022, ' Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC) : A Propensity Score Matched Analysis ', Cancers, vol. 14, no. 4, 887 . https://doi.org/10.3390/cancers14040887Test

مصطلحات موضوعية: Cancer Research, Settore MED/24, cancer-specific survival, Oncology, bcg strain, bcg-rivm, bcg-tice, bladder cancer, progression-free survival, re-tur, recurrence-free survival, re-TUR, BCG-RIVM, BCG strain, BCG-TICE

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc8696fcab0a0e3739ea8410921de520Test
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=8241Test

المؤلفون: Stefano Salciccia, Vittorio Canale, Gian Maria Busetto, Francesco Del Giudice, Matteo Ferro, Isabella Sperduti, Simone Flammia, Simon L. Conti, Martin S. Gross, Martina Maggi, Eila C. Skinner, Ettore De Berardinis, Benjamin I. Chung, Michael L. Eisenberg, Alessandro Sciarra

المصدر: Journal of Cancer Research and Clinical Oncology

مصطلحات موضوعية: Male, Cancer-specific survival, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Original Article – Clinical Oncology, 030232 urology & nephrology, Cystectomy, Resection, BCG Connaught, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, BCG strain, BCG-Connaught, BCG-RIVM, BCG-TICE, bladder cancer, cancer-specific survival, progression-free survival, Re-TUR, recurrence-free survival, Progression-free survival, Aged, Retrospective Studies, Hematology, Bladder cancer, Proportional hazards model, business.industry, General Medicine, Middle Aged, Prognosis, Recurrence-free survival, medicine.disease, Combined Modality Therapy, Survival Rate, Administration, Intravesical, Urinary Bladder Neoplasms, Oncology, 030220 oncology & carcinogenesis, BCG Vaccine, Female, business, Adjuvant, Follow-Up Studies, Cohort study

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf25cd77c7853141cbcc3d8b45077e45Test
https://doi.org/10.1007/s00432-021-03571-0Test

المؤلفون: Witjes, Ja, Dalbagni, G, Karnes, Rj, Shariat, S, Joniau, S, Palou, J, Serretta, V, Larre, S, Colombo, R, Babjuk, M, Malmstrom, P., Malats, N, Irani, J, Baniel, J, Cai, T, Cha, E, Ardelt, P, Varkarakis, J, Bartoletti, R, Spahn, M, Pisano, F, Gontero, P, Sylvester, R., DI STASI, SAVINO MAURO

المساهمون: Witjes, J, Dalbagni, G, Karnes, R, Shariat, S, Joniau, S, Palou, J, Serretta, V, Larre, S, DI STASI, Sm, Colombo, R, Babjuk, M, Malmstrom, P, Malats, N, Irani, J, Baniel, J, Cai, T, Cha, E, Ardelt, P, Varkarakis, J, Bartoletti, R, Spahn, M, Pisano, F, Gontero, P, Sylvester, R

مصطلحات موضوعية: BCG Connaught, BCG Tice, BCG vaccine, Immunotherapy, Intravesical drug administration, T1G3, bladder cancer, high grade, progression, recurrence, Settore MED/24 - UROLOGIA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27639776; info:eu-repo/semantics/altIdentifier/wos/WOS:000392642100010; volume:34; issue:11; firstpage:19; lastpage:25; numberofpages:7; journal:UROLOGIC ONCOLOGY; http://hdl.handle.net/2108/168070Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84994155858

الإتاحة: https://doi.org/10.1016/j.urolonc.2016.05.033Test
http://hdl.handle.net/2108/168070Test

المؤلفون: Rentsch, Cyrill A., Birkhäuser, Frédéric D., Biot, Claire, Gsponer, Joël R., Bisiaux, Aurélie, Wetterauer, Christian, Lagranderie, Micheline, Marchal, Gilles, Orgeur, Mickael, Bouchier, Christiane, Bachmann, Alexander, Ingersoll, Molly A, Brosch, Roland, Albert, Matthew L., Thalmann, George N.

المساهمون: Centre d'immunologie humaine (CIH), Institut Pasteur Paris (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Immunobiologie des Cellules Dendritiques, Department of urology, Universität Bern / University of Bern (UNIBE), Fondation MINES ParisTech, BioTop Institut Pasteur, Pathogénomique mycobactérienne intégrée, Institut Pasteur Paris (IP), Génomique (Plate-Forme) - Genomics Platform, The Cancéropôle Île de France, Ligue Foundation, and the Association for Research on Cancer financed the experimental animal work. Support for the clinical studies was provided by the Swiss National Science Foundation Grant number PSAMP 129381 and by the “Freiwillige Akademische Gesellschaft Basel.” Aurélie Bisiaux was funded by the French Foundation for Medical Research, and Molly A. Ingersoll by the LabEx Immuno-Oncology (Agence Nationale de la Recherche). Mickael Orgeur and Roland Brosch acknowledge support by the European Community's FP7 program under grant agreement number 241745, and FRM DEQ20130326471. Molly A. Ingersoll and Matthew L. Albert acknowledge support by La Ligue Contre le Cancer and Institut National du Cancer, France. The study was also supported by the Swiss Group for Clinical Cancer Research., Cyrill A. Rentsch thanks Stewart T. Cole for his encouragement in initiating this project. Matthew L. Albert thanks the Center for Human Immunology for their support of the work. The clinical study was initiated with the help of the Swiss Group for Clinical Cancer Research (SAKK), and we thank Qiyu Li (SAKK Coordinating Center, Bern, Switzerland) and K. Stucki (Institute of Mathematical Statistics and Actuarial Science, University of Bern, Switzerland) for the support with the statistical analysis of the clinical data. We also thank Wafa Frigui, Romain Veyron-Churlet, and Laurence Ma for their help in genomic DNA and/or library preparation., ANR-11-IDEX-0005,USPC,Université Sorbonne Paris Cité(2011), European Project: 241745,EC:FP7:HEALTH,FP7-HEALTH-2009-single-stage,NEWTBVAC(2010), European Project: FRM-DEQ20100318279,FRM

المصدر: ISSN: 0302-2838.

مصطلحات موضوعية: Urinary bladder neoplasms, BCG vaccine, BCG Connaught, BCG Tice, Intravesical drug administration, Immunotherapy, Randomized controlled trial, Models, Animal, Flow cytometry, MESH: Administration, Intravesical, MESH: Aged, MESH: Mice, Inbred C57BL, MESH: Middle Aged, 80 and over, MESH: Neoplasm Recurrence, Local/mortality, Local/pathology, MESH: Prospective Studies, MESH: Risk Assessment, MESH: Statistics, Nonparametric, MESH: Survival Analysis, MESH: Urinary Bladder Neoplasms/drug therapy, MESH: Dose-Response Relationship, Drug, MESH: Urinary Bladder Neoplasms/mortality, MESH: Urinary Bladder Neoplasms/pathology

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/24674149; info:eu-repo/grantAgreement/EC/FP7/241745/EU/Discovery and preclinical development of new generation tuberculosis vaccines/NEWTBVAC; info:eu-repo/grantAgreement//FRM-DEQ20100318279/EU/FRM /FRM; pasteur-01384198; https://pasteur.hal.science/pasteur-01384198Test; PUBMED: 24674149

الإتاحة: https://doi.org/10.1016/j.eururo.2014.02.061Test
https://pasteur.hal.science/pasteur-01384198Test

المؤلفون: Alexander Bachmann, Aurélie Bisiaux, Roland Brosch, Molly A. Ingersoll, Frédéric D. Birkhäuser, Gilles Marchal, Micheline Lagranderie, Mickael Orgeur, Joel R. Gsponer, Christian Wetterauer, Cyrill A. Rentsch, Matthew L. Albert, Christiane Bouchier, Claire Biot, George N. Thalmann

المساهمون: Centre d'immunologie humaine (CIH), Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Immunobiologie des Cellules Dendritiques, Department of urology, University of Bern, Fondation MINES ParisTech, BioTop Institut Pasteur, Pathogénomique mycobactérienne intégrée, Institut Pasteur [Paris], Génomique (Plate-Forme) - Genomics Platform, The Cancéropôle Île de France, Ligue Foundation, and the Association for Research on Cancer financed the experimental animal work. Support for the clinical studies was provided by the Swiss National Science Foundation Grant number PSAMP 129381 and by the 'Freiwillige Akademische Gesellschaft Basel.' Aurélie Bisiaux was funded by the French Foundation for Medical Research, and Molly A. Ingersoll by the LabEx Immuno-Oncology (Agence Nationale de la Recherche). Mickael Orgeur and Roland Brosch acknowledge support by the European Community's FP7 program under grant agreement number 241745, and FRM DEQ20130326471. Molly A. Ingersoll and Matthew L. Albert acknowledge support by La Ligue Contre le Cancer and Institut National du Cancer, France. The study was also supported by the Swiss Group for Clinical Cancer Research., Cyrill A. Rentsch thanks Stewart T. Cole for his encouragement in initiating this project. Matthew L. Albert thanks the Center for Human Immunology for their support of the work. The clinical study was initiated with the help of the Swiss Group for Clinical Cancer Research (SAKK), and we thank Qiyu Li (SAKK Coordinating Center, Bern, Switzerland) and K. Stucki (Institute of Mathematical Statistics and Actuarial Science, University of Bern, Switzerland) for the support with the statistical analysis of the clinical data. We also thank Wafa Frigui, Romain Veyron-Churlet, and Laurence Ma for their help in genomic DNA and/or library preparation., ANR-11-IDEX-0005,USPC,Université Sorbonne Paris Cité(2011), European Project: 241745,EC:FP7:HEALTH,FP7-HEALTH-2009-single-stage,NEWTBVAC(2010), European Project: FRM-DEQ20100318279,FRM, Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pasteur [Paris] (IP)

المصدر: European Urology
European Urology, Elsevier, 2014, 66 (4), pp.677-688. ⟨10.1016/j.eururo.2014.02.061⟩
European Urology, 2014, 66 (4), pp.677-688. ⟨10.1016/j.eururo.2014.02.061⟩
Eur Urol

مصطلحات موضوعية: Male, medicine.medical_treatment, MESH: Carcinoma, Transitional Cell/mortality, Intravesical drug administration, 030232 urology & nephrology, Kaplan-Meier Estimate, BCG Connaught, MESH: Risk Assessment, law.invention, MESH: Dose-Response Relationship, Drug, Mice, 0302 clinical medicine, MESH: Aged, 80 and over, MESH: Neoplasm Recurrence, Local/pathology, Randomized controlled trial, law, Models, Clinical endpoint, MESH: Animals, Flow cytometry, Prospective Studies, MESH: Aged, Aged, 80 and over, MESH: Statistics, Nonparametric, MESH: Middle Aged, Immunogenicity, MESH: Urinary Bladder Neoplasms/pathology, Middle Aged, 3. Good health, Administration, Intravesical, 030220 oncology & carcinogenesis, MESH: Survival Analysis, MESH: Urinary Bladder Neoplasms/mortality, MESH: BCG Vaccine/administration & dosage, BCG Vaccine, [SDV.IMM]Life Sciences [q-bio]/Immunology, Female, Immunotherapy, MESH: Urinary Bladder Neoplasms/drug therapy, MESH: BCG Vaccine/classification, MESH: Carcinoma, Transitional Cell/drug therapy, Urology, MESH: Neoplasm Recurrence, Local/mortality, MESH: Drug Administration Schedule, complex mixtures, Risk Assessment, Disease-Free Survival, Drug Administration Schedule, Statistics, Nonparametric, 03 medical and health sciences, In vivo, MESH: Mice, Inbred C57BL, MESH: Carcinoma, Transitional Cell/pathology, medicine, Animals, Humans, MESH: Mice, MESH: Kaplan-Meier Estimate, MESH: Administration, Intravesical, Aged, Carcinoma, Transitional Cell, Bladder cancer, MESH: Humans, Dose-Response Relationship, Drug, business.industry, Animal, BCG Tice, medicine.disease, Survival Analysis, MESH: Prospective Studies, MESH: Male, Mice, Inbred C57BL, Urinary Bladder Neoplasms, Immunology, MESH: Disease-Free Survival, Neoplasm Recurrence, Local, business, BCG vaccine, MESH: Female, MESH: Immunotherapy/methods, CD8

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ff25b2981c709a330c86d4b82b4317aTest
https://pubmed.ncbi.nlm.nih.gov/25760254Test

المصدر: Cancers (Basel), 14 (4

مصطلحات الفهرس: Cancérologie, Sciences bio-médicales et agricoles, BCG strain, BCG-RIVM, BCG-TICE, Bladder cancer, Cancer-specific survival, Progression-free survival, Re-TUR, Recurrence-free survival, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article

URL: https://dipot.ulb.ac.be/dspace/bitstream/2013/341547/1/doi_325191.pdfTest
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/341547Test
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLLTest